Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies
Inflammation markers associated with COVID-19 during pregnancy may signal adverse impacts to long-term infant health
25 April 2022New drug combo ‘promising candidate’ for on-demand contraceptive pill
25 April 2022Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies
A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing. SK bioscience, the company leading the vaccine’s clinical development, will seek authorization for its use in South Korea within the month.
